Response to Gammal et al.

Autor: Vassy JL; Section of General Internal Medicine, VA Boston Healthcare System, Boston, MA, USA. jvassy@partners.org.; Department of Medicine, Harvard Medical School, Boston, MA, USA. jvassy@partners.org.; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA. jvassy@partners.org., Stone A; Pharmacogenomics Analysis Laboratory, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA., Callaghan JT; Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.; Indiana University School of Medicine, Indianapolis, IN, USA., Mendes M; VA San Diego Healthcare System, San Diego, CA, USA., Meyer LJ; Office of Specialty Care Services, Veterans Health Administration, Washington, DC, USA., Pratt VM; Indiana University School of Medicine, Indianapolis, IN, USA., Przygodzki RM; Office of Research & Development, US Department of Veterans Affairs, Washington, DC, USA., Scheuner MT; Division of Medical Genetics, Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.; Department of Medicine, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA., Wang-Rodriguez J; VA San Diego Healthcare System, San Diego, CA, USA.; University of California San Diego, San Diego, CA, USA., Schichman SA; Pharmacogenomics Analysis Laboratory, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.
Jazyk: angličtina
Zdroj: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Aug; Vol. 21 (8), pp. 1888-1889. Date of Electronic Publication: 2019 Jan 12.
DOI: 10.1038/s41436-018-0422-9
Databáze: MEDLINE